Book and Media Reviews Section Editor: John L. Zeller, MD, PhD, Fishbein Fellow, JAMA.
Since the cover of Overdose promotes it as “a healthy corrective” to the “often one-sided criticism” that the pharmaceutical industry has come under, I looked forward to reading a spirited response to Angell,1 Kassirer,2 and others. However, Epstein does not take on these critics directly. As a legal scholar, he examines the judicial and political aspects of the regulation of the discovery, approval, marketing, and liability of new pharmaceuticals in the United States.
Rawson NSB. Overdose: How Excessive Government Regulation Stifles Pharmaceutical Innovation. JAMA. 2007;297(6):644-648. doi:10.1001/jama.297.6.646